
亚太地区医用塑料市场预测至 2027 年 - COVID-19 影响和按类型(标准塑料、工程塑料、高性能塑料 (HPP)、硅胶等)和应用(医用一次性用品、假肢、医疗器械和工具、药物输送等)
No. of Pages: 127 | Report Code: TIPRE00017344 | Category: Chemicals and Materials
No. of Pages: 127 | Report Code: TIPRE00017344 | Category: Chemicals and Materials
页数:127 页
医用塑料由大量高分子材料制成,用于生产医疗保健行业中一致且安全的仪器。它们非常耐用、柔软且经济。这些工具的性能、无菌性和质量是市场扩张的主要因素。医用塑料在诊断仪器、植入物、一次性用品、药物输送装置、手术器械、注射器和导管方面有着广泛的应用。预计全球人口在未来几年将会增加。随着人口的增加,疾病和感染通过多种媒介疯狂传播。老年人口的增加进一步促进了医疗保健行业的发展。此外,医用塑料还用于假肢,它为身体残疾的人提供了改变生活的解决方案。
就类型而言,标准塑料细分市场在2019年亚太医用塑料市场中占据最大市场份额。在应用方面,到2027年,医疗应用和工具细分市场将在医用塑料市场中占据最大市场份额。
报告中包含亚太医疗塑料市场的一些主要一手和二手来源是塞拉尼斯公司、伊士曼化学公司、GW Plastics、Orthoplasty Limited、Aran Biomedical、Rochling、SABIC、Saint-Gobain、Solvay 和 Dow。
COVID-19预计将造成超过3%的损失亚太地区10亿。后果和影响可能会更严重,完全取决于病毒的传播。亚太地区政府正在采取可能的措施,通过宣布封锁来减少其影响,从而影响市场产生的收入。国际机场理事会 (ACI) 亚太区警告称,新冠肺炎 (COVID-19) 疫情的持续时间延长将对该地区机场的运营产生严重影响。连通性和经济可持续性,严重限制它们实现先前预测的增长前景。预计此类关闭将对未来一段时间的市场增长产生负面影响。到目前为止,中国的 COVID-19 确诊病例数最多
< p>
Strategic insights for Asia Pacific Medical Plastic involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2019 | US$ 4,745.4 Million |
Market Size by 2027 | US$ 9,023.3 Million |
Global CAGR (2019 - 2027) | 8.4% |
Historical Data | 2017-2018 |
Forecast period | 2020-2027 |
Segments Covered |
By 类型
|
Regions and Countries Covered | 亚太地区
|
Market leaders and key company profiles |
The regional scope of Asia Pacific Medical Plastic refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
Company Profiles
The Asia Pacific Medical Plastic Market is valued at US$ 4,745.4 Million in 2019, it is projected to reach US$ 9,023.3 Million by 2027.
As per our report Asia Pacific Medical Plastic Market, the market size is valued at US$ 4,745.4 Million in 2019, projecting it to reach US$ 9,023.3 Million by 2027. This translates to a CAGR of approximately 8.4% during the forecast period.
The Asia Pacific Medical Plastic Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Medical Plastic Market report:
The Asia Pacific Medical Plastic Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Medical Plastic Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Medical Plastic Market value chain can benefit from the information contained in a comprehensive market report.